PRCN-829

N/A

Report date: 2025/01/26 16:46:38

Base Information

Drug NamePRCN-829
Drug Alias NameAAV-based gene therapy (Neuralgene)PRCN-829
ClassificationBiologics
Mechanisms of ActionLow affinity neurotrophin receptor p75NTR agonistsComplement factor H modulatorsTAR DNA binding protein 43 modulators
TargetsTAR DNA binding protein 43Low affinity neurotrophin receptor p75NTRComplement factor H
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuralgene
China Registration ClassN/A

Develop Information

Active CompaniesNeuralgene
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A